SynthesisFrontiers in immunology2021

Bruton's Tyrosine Kinase (BTK) Inhibitors and Autoimmune Diseases: Making Sense of BTK Inhibitor Specificity Profiles and Recent Clinical Trial Successes and Failures.

Garth E Ringheim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.